Choroidal Neovascularization
📧 Sign up to get email alerts when something new happens for Choroidal Neovascularization.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-03-01Clinical Trial Update: Observation of Treatment Patterns With Lucentis in Approved Indications
An observational study examining how Lucentis is used in approved indications such as neovascular age-related macular degeneration and diabe…
-
CLINICAL_TRIALS withdrawal · 2017-01-06Clinical Trial Update: Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID). [Phase 2]
A Phase II study evaluating aflibercept for choroidal neovascularization associated with angioid streaks has been withdrawn. The sponsor lis…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD [Phase 3]
A Phase 3 randomized study evaluated ranibizumab 0.5 mg using treat-extend and monthly regimens in neovascular age-related macular degenerat…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) [Phase 3]
This clinical trial update reports efficacy and safety results from the EXTEND III Phase 3 study of ranibizumab in patients with subfoveal c…
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Conbercept in Choroidal Neovascularization Secondary to Uveitis [Phase 2]
Phase 2 clinical trial evaluating conbercept for choroidal neovascularization secondary to uveitis; current status is not disclosed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-09-21Clinical Trial Update: Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)
The clinical trial comparing a home macular perimeter with OCT for assessing visual field defects in choroidal neovascularization has been w…
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. [Phase 3]
Phase 3 trial results and completion update for intravitreal ranibizumab in patients with vision loss due to choroidal neovascularization (C…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT) [Phase 2]
This Phase 2 trial assessing bevacizumab in combination with Visudyne photodynamic therapy for age-related macular degeneration and related …
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen [Phase 2]
Phase 2 study evaluating an individualized regimen of ranibizumab for choroidal neovascularization caused by pathological myopia; study comp…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Intravitreal Bevacizumab in Agioid Streaks [Phase 1]
A Phase 1 study evaluating intravitreal bevacizumab for Angioid Streaks with choroidal neovascularization has completed.
-
CLINICAL_TRIALS withdrawal · 2015-12-31Clinical Trial Update: Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration [Phase 1]
Phase 1 trial evaluating imatinib mesylate with intravitreal ranibizumab for choroidal neovascularization due to age-related macular degener…
-
CLINICAL_TRIALS research · 2015-09-18Clinical Trial Update: Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD
A completed genetic analysis study investigating chronic central serous chorioretinopathy that masquerades as neovascular age-related macula…
-
CLINICAL_TRIALS withdrawal · 2015-08-13Clinical Trial Update: Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy [Phase 4]
A Phase 4 clinical trial evaluating a triple treatment for detachment of the retinal pigment epithelium secondary to polypoidal choroidal va…
-
CLINICAL_TRIALS withdrawal · 2015-07-07Clinical Trial Update: Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration [Phase 1]
Phase 1 clinical trial evaluating the combination of efalizumab and intravitreal ranibizumab for age-related macular degeneration was withdr…
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Sensitivity of the Home Macular Perimeter (HMP)
This completed clinical trial update assesses the sensitivity of the Home Macular Perimeter (HMP) in participants with age-related macular d…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) [Phase 2]
Phase 2 dose-escalation study of PF-04523655, with and without ranibizumab, in diabetic macular edema, with exploration in related retinal d…
-
CLINICAL_TRIALS withdrawal · 2014-11-21Clinical Trial Update: Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)? [NA]
This clinical trial examining whether VEGF or CFH gene polymorphisms influence response to VEGF inhibitors in choroidal neovascularization a…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: 20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD) [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating intravitreal injections combining triamcinolone acetonide with ranibizumab (Lucentis) for neovascular …
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration
This clinical trial update reports the completion of a study evaluating the ForeseeHome home vision monitoring device after treatment of neo…
-
CLINICAL_TRIALS research · 2014-06-04Clinical Trial Update: A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV [Phase 3]
Phase 3 randomized, double-blind, multicenter, sham-controlled study assessing the safety and efficacy of Conbercept in patients with myopic…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV) [Phase 3]
Phase 3 trial evaluating VEGF Trap-Eye for choroidal neovascularization due to pathologic myopia has completed, with results posted in 2014.…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [Phase 3]
Phase 3 trial evaluating ranibizumab for choroidal neovascularization secondary to age-related macular degeneration has completed.
-
CLINICAL_TRIALS withdrawal · 2014-01-14Clinical Trial Update: Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD [NA]
A clinical trial comparing intravitreal bevacizumab versus combination therapy for choroidal neovascularization due to conditions other than…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Evaluation of Dosing Interval of Higher Doses of Ranibizumab [Phase 4]
A Phase 4 clinical trial evaluated dosing intervals for higher doses of ranibizumab in age-related macular degeneration and choroidal neovas…
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia [Phase 1]
Phase 1 trial evaluating reduced-fluence verteporfin photodynamic therapy in combination with ranibizumab for choroidal neovascularization i…